At a glance
- Originator Janssen L.P.
- Class Antiallergics; Antiasthmatics
- Mechanism of Action Interleukin 5 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory tract disorders